Case Studies
21.02.2019
Outsourcing pricing activities for large biotech

Enabled a biotech to achieve its targets by provision of expert pricing support during a company res...

Read more
Case Studies
21.02.2019
Payer willingness to pay

Review of secondary literature and clinical trial databases to understand payer willingness to pay.

Read more
Articles
11.02.2019
NICE Scientific Advice

The collaboration with the Ethical Medicines Industry Group (EMIG) will help bring greater understan...

Read more
News
06.02.2019
Kymriah gets NICE approval for DLBCL

The only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...

Read more
Articles
29.01.2019
Voluntary scheme for branded medicines pricing

Overall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...

Read more
Publications
17.01.2019
Early payer scientific advice procedures

The objective of this research was to understand the processes and outputs from different European p...

Read more
Articles
12.12.2018
Medicare drug pricing

Medicare would use a new International Pricing Index (IPI) model that considers international refere...

Read more
News
19.11.2018
Pfizer hike list price of 41 medicines

Pfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire ...

Read more
Publications
14.11.2018
ISPOR 2018 Companies market access training

Setting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...

Read more
Articles
24.10.2018
Patient access to high-cost orphan drugs

Orphan drugs have important societal value as they improve patient quality of life and address unmet...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.